These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1421633)

  • 21. [Chilblain lupus erythematosus. A case report].
    Brado B; Keilholz U; Tilgen W; Pezzutto A; Gissler M; Hunstein W
    Internist (Berl); 1992 Oct; 33(10):701-3. PubMed ID: 1428687
    [No Abstract]   [Full Text] [Related]  

  • 22. A homozygote TREX1 mutation in two siblings with different phenotypes: Chilblains and cerebral vasculitis.
    Kisla Ekinci RM; Balci S; Bisgin A; Altintas DU; Yilmaz M
    Eur J Med Genet; 2017 Dec; 60(12):690-694. PubMed ID: 28919362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chilblain lupus erythematosus in a patient affected by Hodgkin lymphoma.
    Passarini B; Pileri A; Neri I; Piraccini BM; Reggiani C; Patrizi A
    Australas J Dermatol; 2013 Feb; 54(1):74-5. PubMed ID: 23373885
    [No Abstract]   [Full Text] [Related]  

  • 24. Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3' repair exonuclease 1 (TREX1).
    Günther C; Berndt N; Wolf C; Lee-Kirsch MA
    JAMA Dermatol; 2015 Apr; 151(4):426-31. PubMed ID: 25517357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted Treatment of TREX1 Chilblain Lupus and Other Interferonopathies-Taming T REX.
    Damsky W; King BA
    JAMA Dermatol; 2019 Mar; 155(3):283-284. PubMed ID: 30673073
    [No Abstract]   [Full Text] [Related]  

  • 26. Cutaneous sarcoidosis: Lupus pernio and more.
    Randhawa KS; Lee BW; Micali G; Benson BE; Schwartz RA
    Ital J Dermatol Venerol; 2022 Jun; 157(3):220-227. PubMed ID: 35274876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of chilblain lupus erythematosus with lupus erythematosus/lichen planus overlap syndrome.
    Komori T; Otsuka A; Honda T; Kaku Y; Kabashima K
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e424-e425. PubMed ID: 28322475
    [No Abstract]   [Full Text] [Related]  

  • 28. Postsurgical Appearance of Chilblains Lupus Erythematosus.
    Fulton HM; Fulton DB
    J Hand Surg Glob Online; 2021 Sep; 3(5):302-305. PubMed ID: 35415566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sarcoidosis with Lupus Pernio in an Afro-Caribbean Man.
    Ali K; Mohammed S; Persad D; Jaggernauth J; Sakhamuri S; Teelucksingh S
    Am J Med; 2023 Apr; 136(4):e67-e68. PubMed ID: 36649836
    [No Abstract]   [Full Text] [Related]  

  • 30. Chilblain lupus erythematosus treated successfully with mycophenolate mofetil.
    Gouillon L; Debarbieux S; Berruyer M; Fabien N; Lega JC; Thomas L
    Int J Dermatol; 2017 Aug; 56(8):e158-e159. PubMed ID: 28345755
    [No Abstract]   [Full Text] [Related]  

  • 31. Sarcoidosis mimicking malar rash: a case of lupus pernio.
    Sato R; Kiniwa Y; Shirai T; Okuyama R
    Eur J Dermatol; 2019 Jun; 29(3):331-332. PubMed ID: 31145098
    [No Abstract]   [Full Text] [Related]  

  • 32. Chilblain lupus erythematosus is associated with antibodies to SSA/Ro.
    Franceschini F; Calzavara-Pinton P; Quinzanini M; Cavazzana I; Bettoni L; Zane C; Facchetti F; Airò P; McCauliffe DP; Cattaneo R
    Lupus; 1999; 8(3):215-9. PubMed ID: 10342714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chilblain lesions associated with inherited autoimmune disease.
    Rutsch F
    Br J Dermatol; 2015 Dec; 173(6):1369-70. PubMed ID: 26708548
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of the past history of chilblain in cases of systemic lupus erythematosus (SLE) and its similar diseases].
    Morioka N; Tsuchida T; Ueda Y; Ishibashi Y
    Nihon Hifuka Gakkai Zasshi; 1991 May; 101(6):615-22. PubMed ID: 1920892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of lenalidomide in refractory lupus pernio.
    Dalm VA; van Hagen PM
    JAMA Dermatol; 2013 Apr; 149(4):493-4. PubMed ID: 23715134
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chilblain lupus in an adolescent].
    Brănişteanu DE; Molodoi AD; Stătescu L; Petrescu Z; Vasiluţ D; Anisiei E; Ferariu D; Brănişteanu D
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):646-51. PubMed ID: 20201246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chilblains in immune-mediated inflammatory diseases: a review.
    Dubey S; Joshi N; Stevenson O; Gordon C; Reynolds JA
    Rheumatology (Oxford); 2022 Nov; 61(12):4631-4642. PubMed ID: 35412601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lupus pernio: Skin manifestation of systemic disease.
    Srivali N; De Giacomi F
    Eur J Intern Med; 2021 Oct; 92():113-114. PubMed ID: 34465520
    [No Abstract]   [Full Text] [Related]  

  • 39. Chilblain lupus-like cutaneous reaction associated with systemic lupus erythematosus induced by immune checkpoint inhibitor.
    Takeda K; Nakano K; Udagawa S; Fukuda N; Nishizawa A; Ono M; Urasaki T; Tomomatsu J; Mochizuki T; Shiga T; Kogawa T; Takahashi S; Kitano S
    Rheumatology (Oxford); 2021 Dec; 61(1):e13-e14. PubMed ID: 34463707
    [No Abstract]   [Full Text] [Related]  

  • 40. Familial Chilblain Lupus - What Can We Learn from Type I Interferonopathies?
    Fiehn C
    Curr Rheumatol Rep; 2017 Aug; 19(10):61. PubMed ID: 28844088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.